128 related articles for article (PubMed ID: 752306)
1. Antibody responses to influenza vaccines containing A/New Jersey/8/76.
Feery BJ; Hampson AW; Rodda SJ; Evered MG
Aust J Exp Biol Med Sci; 1978 Dec; 56(6):639-47. PubMed ID: 752306
[TBL] [Abstract][Full Text] [Related]
2. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.
Masurel N; Laufer J
J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638
[TBL] [Abstract][Full Text] [Related]
3. [Antibody response to hemagglutinin and neuraminidase induced by an influenza subunit vaccine (author's transl)].
Kuwert E; Werner J; Franke G; Paulus W
Zentralbl Bakteriol Orig A; 1979 Jun; 244(1):1-16. PubMed ID: 92113
[TBL] [Abstract][Full Text] [Related]
4. Serological response to an adsorbed killed trivalent influenza vaccine (including A/New Jersey 8/76 antigen).
Sarateanu D; Ehrengut W; Pressler K
Dev Biol Stand; 1977 Jun 1-3; 39():235-8. PubMed ID: 604102
[TBL] [Abstract][Full Text] [Related]
5. [Local and systemic antibody response after vaccination with 3 different types of vaccines against influenza. II. Neuraminidase inhibiting antibodies (author's transl)].
Werner J; Kuwert EK; Stegmaier R; Simböck H
Zentralbl Bakteriol A; 1980 Feb; 246(1):1-9. PubMed ID: 7424233
[TBL] [Abstract][Full Text] [Related]
6. IgM and IgG antibody responses after immunization of children with inactivated monovalent (A/New Jersey/76) and bivalent (A/New Jersey/76-A/Victoria/75) influenza virus vaccines.
Boyer KM; Cherry JD; Welliver RC; Dudley JP; Deseda-Tous J; Zahradnik JM; Krause PJ; Spencer MJ; Bryson YJ; Garakian AJ
J Infect Dis; 1977 Dec; 136 Suppl():S665-71. PubMed ID: 342632
[TBL] [Abstract][Full Text] [Related]
7. Persistence of influenza A/New Jersey/76 (Hsw1N1) antibody one year after vaccination.
Noble GR; Kaye HS; O'Brien RJ; Kendal AP; Bregman DJ; Wright PF; Amler RW; Dowdle WR
Dev Biol Stand; 1977 Jun 1-3; 39():253-60. PubMed ID: 604107
[TBL] [Abstract][Full Text] [Related]
8. Human responses to purified surface antigen invluenza vaccine (Fluvirin).
Stones PB; Furminger IG; Kerr J
Dev Biol Stand; 1977 Jun 1-3; 39():239-42. PubMed ID: 604103
[TBL] [Abstract][Full Text] [Related]
9. The importance of antineuraminidase antibodies in resistance to influenza A and immunologic memory for their synthesis.
Naikhin AN; Tsaritsina IM; Oleinikova EV; Syrodoeva LG; Korchanova NL; Denisov GM; Shvartsman YaS
J Hyg (Lond); 1983 Aug; 91(1):131-8. PubMed ID: 6886409
[TBL] [Abstract][Full Text] [Related]
10. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
[No Abstract] [Full Text] [Related]
11. Persistence of influenza serum antibodies in humans following immunization with a bivalent A/Victoria and A/New Jersey vaccine.
Boucher DW; Contreras G; Furesz J
Can Med Assoc J; 1979 Apr; 120(7):799-802, 831. PubMed ID: 427686
[TBL] [Abstract][Full Text] [Related]
12. Antibody response to influenza A/New Jersey and A/Victoria virus vaccines in 1976 and subsequent antibody levels after influenza A epidemics, 1977-1979.
Foy HM; Cooney MK; Taylor J; Allan I; Chuang TY; Blumhagen J; Fox JP
J Infect Dis; 1980 Aug; 142(2):139-44. PubMed ID: 7410896
[TBL] [Abstract][Full Text] [Related]
13. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL
J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981
[TBL] [Abstract][Full Text] [Related]
14. Cell-mediated immune responses to the hemagglutinin and neuraminidase antigens of influenza A virus after immunization in humans.
Chow TC; Beutner KR; Ogra PL
Infect Immun; 1979 Jul; 25(1):103-9. PubMed ID: 478632
[TBL] [Abstract][Full Text] [Related]
15. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909
[TBL] [Abstract][Full Text] [Related]
16. Antibody responses and reactogenicity of graded doses of inactivated influenza A/New Jersey/76 whole-virus vaccine in humans.
J Infect Dis; 1977 Dec; 136 Suppl():S475-83. PubMed ID: 342621
[TBL] [Abstract][Full Text] [Related]
17. Clinical trials with inactivated monovalent (A/New Jersey/76) and bivalent (A/New Jersey/76-A/Victoria/75) influenza vaccines in Los Angeles children.
Boyer KM; Cherry JD; Welliver RC; Deseda-Tous J; Zahradnik JM; Dudley JP; Krause PJ; Bryson YJ; Spencer MJ
J Infect Dis; 1977 Dec; 136 Suppl():S661-4. PubMed ID: 342631
[TBL] [Abstract][Full Text] [Related]
18. Serological response to whole, split and subunit influenza vaccines of persons with and without immunological experience towards influenza A/U.S.S.R. 90/77 virus.
Sarateanu DE; Ehrengut W; Pressler K; Peukert M; Schenk KD
Comp Immunol Microbiol Infect Dis; 1980; 3(1-2):225-36. PubMed ID: 7471712
[No Abstract] [Full Text] [Related]
19. Serologic responses and systemic reactions in adults after vaccination with bivalent A/Victoria/75-A/New Jersey/76 and monovalent B/Hong Kong/72 influenza vaccines.
Wise TG; Dolin R; Mazur MH; Top FH; Edelman R; Ennis FA
J Infect Dis; 1977 Dec; 136 Suppl():S507-17. PubMed ID: 342623
[TBL] [Abstract][Full Text] [Related]
20. Clinical trials of bivalent influenza A/New Jersey/76-A/Victoria/75 vaccines in the elderly.
Cate TR; Kasel JA; Couch RB; Six HR; Knight V
J Infect Dis; 1977 Dec; 136 Suppl():S518-25. PubMed ID: 342624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
